+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vinpocetine Market By Product Type: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 280 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994234
Description Jump to:
The vinpocetine market was valued at $0.2 billion in 2023 and is projected to reach $0.3 billion by 2033, growing at a CAGR of 3.5% from 2024 to 2033.

Vinpocetine is a synthetic chemical that holds resemblance with a natural compound derived from the plant Vinca minor. The compound is a multi-action agent used to treat various conditions and diseases, including head injuries, stroke, dementia during Parkinson’s disease, age-related memory loss, and Alzheimer’s disease. The primary action mechanism of vinpocetine involves the enhancement of cerebral blood flow, resulting in improved nutrient and oxygen delivery to the brain. Owing to its remarkable safety profile, the chemical has been made available in the form of dietary supplement for enhanced cognition and memory.

Increase in the prevalence of cognitive disorders, particularly due to exponential growth in the elderly population has significantly driven the growth of the vinpocetine market. In addition, with rising awareness regarding the timely prevention of neurodegenerative diseases, individuals are beginning the consumption of dietary supplements as a precautionary measure, thereby boosting the demand for vinpocetine. The expanding landscape of dietary supplements augments the growth of the market notably. Currently, explorations regarding the applications of vinpocetine beyond its cognitive support are trending. The chemical has been tested for the treatment of diverse conditions such as atherosclerosis and injured alveolar epithelial cells in pulmonary fibrosis. Such expansion of applications is projected to present new segments for market development.

However, the chemical faces different regulatory hurdles in several countries owing to its classification and efficacy, which restrains the widespread growth of the market. Furthermore, several alternative and competent alternatives are available for the treatment of Alzheimer’s and dementia, hampering market development. For instance, the U.S. Food and Drug Administration and recently approved the efficacy of a novel drug - lecanemab - an anti-amyloid monoclonal antibody, for the treatment of dementia. The drug particularly targets the elementary causes of the disease by binding to amyloid-beta plaques, the hallmark of the disease. Different studies have advocated for the effectiveness of lecanemab, presenting challenges for the expansion of the vinpocetine market.

Segment Review

The vinpocetine market is segmented into product type, distribution channel, and region. On the basis of product type, the market is bifurcated into tablet and injection. As per distribution channel, it is divided into retail pharmacies, hospital pharmacies, and online pharmacies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product type, the tablet segment acquired a high stake in the market in 2023.

As per distribution channel, the retail pharmacies segment accounted for a high market share in 2023.

Region wise, North America holds a dominant position in the vinpocetine market.

Competition Analysis

The leading players operating in the global vinpocetine market include Northeast Pharmaceutical Group Co., Ltd., Gedeon Richter, COVEX, Runhong, Liaoning Zhiying, Sun Pharmaceuticals Industries Ltd, Welman, and Micro Labs Ltd. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • New Product Development/ Product Matrix of Key Players
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product Type

  • Tablet
  • Injection

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
Key Market Players
  • Northeast Pharmaceutical Group Co., Ltd.
  • COVEX
  • Runhong
  • Liaoning Zhiying
  • Sun Pharmaceuticals Industries Ltd
  • Welman
  • Micro Labs Ltd
  • Gedeon Richter Plc.

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: VINPOCETINE MARKET, BY PRODUCT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product Type
4.2. Tablet
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Injection
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: VINPOCETINE MARKET, BY DISTRIBUTION CHANNEL
5.1. Market Overview
5.1.1 Market Size and Forecast, By Distribution Channel
5.2. Retail Pharmacies
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Hospital Pharmacies
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Online Pharmacies
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: VINPOCETINE MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product Type
6.2.3. Market Size and Forecast, By Distribution Channel
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Vinpocetine Market
6.2.5.1. Market Size and Forecast, By Product Type
6.2.5.2. Market Size and Forecast, By Distribution Channel
6.2.6. Canada Vinpocetine Market
6.2.6.1. Market Size and Forecast, By Product Type
6.2.6.2. Market Size and Forecast, By Distribution Channel
6.2.7. Mexico Vinpocetine Market
6.2.7.1. Market Size and Forecast, By Product Type
6.2.7.2. Market Size and Forecast, By Distribution Channel
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product Type
6.3.3. Market Size and Forecast, By Distribution Channel
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Vinpocetine Market
6.3.5.1. Market Size and Forecast, By Product Type
6.3.5.2. Market Size and Forecast, By Distribution Channel
6.3.6. France Vinpocetine Market
6.3.6.1. Market Size and Forecast, By Product Type
6.3.6.2. Market Size and Forecast, By Distribution Channel
6.3.7. UK Vinpocetine Market
6.3.7.1. Market Size and Forecast, By Product Type
6.3.7.2. Market Size and Forecast, By Distribution Channel
6.3.8. Italy Vinpocetine Market
6.3.8.1. Market Size and Forecast, By Product Type
6.3.8.2. Market Size and Forecast, By Distribution Channel
6.3.9. Spain Vinpocetine Market
6.3.9.1. Market Size and Forecast, By Product Type
6.3.9.2. Market Size and Forecast, By Distribution Channel
6.3.10. Rest of Europe Vinpocetine Market
6.3.10.1. Market Size and Forecast, By Product Type
6.3.10.2. Market Size and Forecast, By Distribution Channel
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product Type
6.4.3. Market Size and Forecast, By Distribution Channel
6.4.4. Market Size and Forecast, By Country
6.4.5. Japan Vinpocetine Market
6.4.5.1. Market Size and Forecast, By Product Type
6.4.5.2. Market Size and Forecast, By Distribution Channel
6.4.6. China Vinpocetine Market
6.4.6.1. Market Size and Forecast, By Product Type
6.4.6.2. Market Size and Forecast, By Distribution Channel
6.4.7. Australia Vinpocetine Market
6.4.7.1. Market Size and Forecast, By Product Type
6.4.7.2. Market Size and Forecast, By Distribution Channel
6.4.8. India Vinpocetine Market
6.4.8.1. Market Size and Forecast, By Product Type
6.4.8.2. Market Size and Forecast, By Distribution Channel
6.4.9. South Korea Vinpocetine Market
6.4.9.1. Market Size and Forecast, By Product Type
6.4.9.2. Market Size and Forecast, By Distribution Channel
6.4.10. Rest of Asia-Pacific Vinpocetine Market
6.4.10.1. Market Size and Forecast, By Product Type
6.4.10.2. Market Size and Forecast, By Distribution Channel
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product Type
6.5.3. Market Size and Forecast, By Distribution Channel
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Vinpocetine Market
6.5.5.1. Market Size and Forecast, By Product Type
6.5.5.2. Market Size and Forecast, By Distribution Channel
6.5.6. Saudi Arabia Vinpocetine Market
6.5.6.1. Market Size and Forecast, By Product Type
6.5.6.2. Market Size and Forecast, By Distribution Channel
6.5.7. South Africa Vinpocetine Market
6.5.7.1. Market Size and Forecast, By Product Type
6.5.7.2. Market Size and Forecast, By Distribution Channel
6.5.8. Rest of LAMEA Vinpocetine Market
6.5.8.1. Market Size and Forecast, By Product Type
6.5.8.2. Market Size and Forecast, By Distribution Channel
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Northeast Pharmaceutical Group Co., Ltd.
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. COVEX
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Runhong
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Liaoning Zhiying
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Sun Pharmaceuticals Industries Ltd
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Welman
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Micro Labs Ltd
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Gedeon Richter Plc.
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 2. Vinpocetine Market for Tablet, by Region, 2024 - 2033 ($Billion)
Table 3. Vinpocetine Market for Injection, by Region, 2024 - 2033 ($Billion)
Table 4. Global Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 5. Vinpocetine Market for Retail Pharmacies, by Region, 2024 - 2033 ($Billion)
Table 6. Vinpocetine Market for Hospital Pharmacies, by Region, 2024 - 2033 ($Billion)
Table 7. Vinpocetine Market for Online Pharmacies, by Region, 2024 - 2033 ($Billion)
Table 8. Vinpocetine Market, by Region, 2024 - 2033 ($Billion)
Table 9. North America Vinpocetine Market, by Country, 2024 - 2033 ($Billion)
Table 10. North America Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 11. North America Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 12. U.S. Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 13. U.S. Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 14. Canada Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 15. Canada Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 16. Mexico Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 17. Mexico Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 18. Europe Vinpocetine Market, by Country, 2024 - 2033 ($Billion)
Table 19. Europe Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 20. Europe Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 21. Germany Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 22. Germany Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 23. France Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 24. France Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 25. UK Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 26. UK Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 27. Italy Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 28. Italy Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 29. Spain Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 30. Spain Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 31. Rest of Europe Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 32. Rest of Europe Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 33. Asia-Pacific Vinpocetine Market, by Country, 2024 - 2033 ($Billion)
Table 34. Asia-Pacific Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 35. Asia-Pacific Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 36. Japan Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 37. Japan Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 38. China Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 39. China Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 40. Australia Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 41. Australia Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 42. India Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 43. India Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 44. South Korea Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 45. South Korea Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 46. Rest of Asia-Pacific Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 47. Rest of Asia-Pacific Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 48. LAMEA Vinpocetine Market, by Country, 2024 - 2033 ($Billion)
Table 49. LAMEA Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 50. LAMEA Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 51. Brazil Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 52. Brazil Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 53. Saudi Arabia Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 54. Saudi Arabia Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 55. South Africa Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 56. South Africa Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 57. Rest of LAMEA Vinpocetine Market, by Product Type, 2024 - 2033 ($Billion)
Table 58. Rest of LAMEA Vinpocetine Market, by Distribution Channel, 2024 - 2033 ($Billion)
Table 59. Northeast Pharmaceutical Group Co. Ltd.: Key Executives
Table 60. Northeast Pharmaceutical Group Co. Ltd.: Company Snapshot
Table 61. Northeast Pharmaceutical Group Co. Ltd.: Operating Segments
Table 62. Northeast Pharmaceutical Group Co. Ltd.: Product Portfolio
Table 63. Northeast Pharmaceutical Group Co. Ltd.: Key Strategic Moves and Developments
Table 64. Covex: Key Executives
Table 65. Covex: Company Snapshot
Table 66. Covex: Operating Segments
Table 67. Covex: Product Portfolio
Table 68. Covex: Key Strategic Moves and Developments
Table 69. Runhong: Key Executives
Table 70. Runhong: Company Snapshot
Table 71. Runhong: Operating Segments
Table 72. Runhong: Product Portfolio
Table 73. Runhong: Key Strategic Moves and Developments
Table 74. Liaoning Zhiying: Key Executives
Table 75. Liaoning Zhiying: Company Snapshot
Table 76. Liaoning Zhiying: Operating Segments
Table 77. Liaoning Zhiying: Product Portfolio
Table 78. Liaoning Zhiying: Key Strategic Moves and Developments
Table 79. Sun Pharmaceuticals Industries Ltd.: Key Executives
Table 80. Sun Pharmaceuticals Industries Ltd.: Company Snapshot
Table 81. Sun Pharmaceuticals Industries Ltd.: Operating Segments
Table 82. Sun Pharmaceuticals Industries Ltd.: Product Portfolio
Table 83. Sun Pharmaceuticals Industries Ltd.: Key Strategic Moves and Developments
Table 84. Welman: Key Executives
Table 85. Welman: Company Snapshot
Table 86. Welman: Operating Segments
Table 87. Welman: Product Portfolio
Table 88. Welman: Key Strategic Moves and Developments
Table 89. Micro Labs Ltd.: Key Executives
Table 90. Micro Labs Ltd.: Company Snapshot
Table 91. Micro Labs Ltd.: Operating Segments
Table 92. Micro Labs Ltd.: Product Portfolio
Table 93. Micro Labs Ltd.: Key Strategic Moves and Developments
Table 94. Gedeon Richter PLC.: Key Executives
Table 95. Gedeon Richter PLC.: Company Snapshot
Table 96. Gedeon Richter PLC.: Operating Segments
Table 97. Gedeon Richter PLC.: Product Portfolio
Table 98. Gedeon Richter PLC.: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Vinpocetine Market, 2024 - 2033
Figure 2. Segmentation of Vinpocetine Market, 2024 - 2033
Figure 3. Top Investment Pocket in Vinpocetine Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalvinpocetine Market
Figure 10. Global Vinpocetine Market Segmentation, by Product Type
Figure 11. Vinpocetine Market for Tablet, by Country, 2024 - 2033 ($Billion)
Figure 12. Vinpocetine Market for Injection, by Country, 2024 - 2033 ($Billion)
Figure 13. Global Vinpocetine Market Segmentation, by Distribution Channel
Figure 14. Vinpocetine Market for Retail Pharmacies, by Country, 2024 - 2033 ($Billion)
Figure 15. Vinpocetine Market for Hospital Pharmacies, by Country, 2024 - 2033 ($Billion)
Figure 16. Vinpocetine Market for Online Pharmacies, by Country, 2024 - 2033 ($Billion)
Figure 17. Top Winning Strategies, by Year, 2021-2023*
Figure 18. Top Winning Strategies, by Development, 2021-2023*
Figure 19. Top Winning Strategies, by Company, 2021-2023*
Figure 20. Product Mapping of Top 10 Players
Figure 21. Competitive Dashboard
Figure 22. Competitive Heatmap: Vinpocetine Market
Figure 23. Top Player Positioning, 2023
Figure 24. Northeast Pharmaceutical Group Co. Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 25. Northeast Pharmaceutical Group Co. Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 26. Northeast Pharmaceutical Group Co. Ltd.: Revenue Share, by Region, 2023 (%)
Figure 27. Covex: Net Sales, 2021-2023 ($Billion)
Figure 28. Covex: Revenue Share, by Segment, 2023 (%)
Figure 29. Covex: Revenue Share, by Region, 2023 (%)
Figure 30. Runhong: Net Sales, 2021-2023 ($Billion)
Figure 31. Runhong: Revenue Share, by Segment, 2023 (%)
Figure 32. Runhong: Revenue Share, by Region, 2023 (%)
Figure 33. Liaoning Zhiying: Net Sales, 2021-2023 ($Billion)
Figure 34. Liaoning Zhiying: Revenue Share, by Segment, 2023 (%)
Figure 35. Liaoning Zhiying: Revenue Share, by Region, 2023 (%)
Figure 36. Sun Pharmaceuticals Industries Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 37. Sun Pharmaceuticals Industries Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 38. Sun Pharmaceuticals Industries Ltd.: Revenue Share, by Region, 2023 (%)
Figure 39. Welman: Net Sales, 2021-2023 ($Billion)
Figure 40. Welman: Revenue Share, by Segment, 2023 (%)
Figure 41. Welman: Revenue Share, by Region, 2023 (%)
Figure 42. Micro Labs Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 43. Micro Labs Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 44. Micro Labs Ltd.: Revenue Share, by Region, 2023 (%)
Figure 45. Gedeon Richter PLC.: Net Sales, 2021-2023 ($Billion)
Figure 46. Gedeon Richter PLC.: Revenue Share, by Segment, 2023 (%)
Figure 47. Gedeon Richter PLC.: Revenue Share, by Region, 2023 (%)

Companies Mentioned

Key Market Players in the Vinpocetine Market include:
  • Northeast Pharmaceutical Group Co., Ltd.
  • COVEX
  • Runhong
  • Liaoning Zhiying
  • Sun Pharmaceuticals Industries Ltd
  • Welman
  • Micro Labs Ltd
  • Gedeon Richter Plc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages280
PublishedJuly 2024
Forecast Period2023 - 2033
Estimated Market Value ( USD ) in 2023 $ 0.2 billion
Forecasted Market Value ( USD ) by 2033 $ 0.3 billion
Compound Annual Growth Rate3.5%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Vinpocetine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

Vinpocetine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 103 Pages
  • Global
From
Vinpocetine (CAS 42971-09-5) Global Market Research Report 2024 - Product Image

Vinpocetine (CAS 42971-09-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Mens Health Supplements Market By Product Type: Global Opportunity Analysis and Industry Forecast, 2024-2033 - Product Image

Mens Health Supplements Market By Product Type: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • 216 Pages
  • Global
From
Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market - A Global and Regional Analysis: Focus on Product, Indication, Formulation, Sales Channel, Region, Country-Level Analysis, and Competitive Landscape - Analysis and Forecast, 2024-2033 - Product Image

Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market - A Global and Regional Analysis: Focus on Product, Indication, Formulation, Sales Channel, Region, Country-Level Analysis, and Competitive Landscape - Analysis and Forecast, 2024-2033

  • Report
  • 167 Pages
  • Global
From
Cognitive Supplements Global Market Report 2024 - Product Image

Cognitive Supplements Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.